ID
41371
Beschrijving
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. See https://clinicaltrials.gov/ct2/show/NCT00039858 This Form is to be completed on Study Conclusion and is used to verify that no important steps were omitted. Also includes Investigator's Signature.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Trefwoorden
Versies (1)
- 14-09-20 14-09-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
14 september 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Study Completion
- StudyEvent: ODM
Beschrijving
Study Completion
Alias
- UMLS CUI-1
- C2348577
Beschrijving
If b. = YES, complete below (indicate all that apply):
Alias
- UMLS CUI-1
- C2348577
Beschrijving
Resolution of underlying condition requiring anticoagulation
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514893
- UMLS CUI [1,2]
- C0277554
- UMLS CUI [1,3]
- C0449867
- UMLS CUI [1,4]
- C1514873
Beschrijving
Oral or subcutaneous anticoagulation therapy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0003281
- UMLS CUI [1,2]
- C1527415
- UMLS CUI [2,1]
- C0003281
- UMLS CUI [2,2]
- C0443315
Beschrijving
Study drug trial period complete
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0205197
- UMLS CUI [1,3]
- C2347804
Beschrijving
If b. = NO, indicate reason(s) below: (indicate all that apply)
Alias
- UMLS CUI-1
- C2348577
- UMLS CUI-2
- C1272696
Beschrijving
Major bleed
Datatype
boolean
Alias
- UMLS CUI [1]
- C3160769
Beschrijving
Bleeding unresponsive to treatment
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C0205269
Beschrijving
Interruption of infusion procedures
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1512900
- UMLS CUI [1,2]
- C0574032
Beschrijving
Adverse event
Datatype
boolean
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Adverse event - specify
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1521902
Beschrijving
Intercurrent Illness
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschrijving
Intercurrent Illness - specify
Datatype
text
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C1521902
Beschrijving
Protocol violation
Datatype
boolean
Alias
- UMLS CUI [1]
- C1709750
Beschrijving
Protocol violation - specify
Datatype
text
Alias
- UMLS CUI [1,1]
- C1709750
- UMLS CUI [1,2]
- C1521902
Beschrijving
Surgery
Datatype
boolean
Alias
- UMLS CUI [1]
- C0543467
Beschrijving
Surgery - specify
Datatype
text
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C1521902
Beschrijving
Lack of drug efficacy | drug efficacy insuficient
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0235828
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [2,1]
- C0598333
- UMLS CUI [2,2]
- C0231180
Beschrijving
Withdrawal by subject
Datatype
boolean
Alias
- UMLS CUI [1]
- C1710677
Beschrijving
Other reason why study not completed by subject
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2348577
- UMLS CUI [1,2]
- C1272696
- UMLS CUI [1,3]
- C3840932
Beschrijving
Other reason why study not completed by subject - specify
Datatype
text
Alias
- UMLS CUI [1,1]
- C2348577
- UMLS CUI [1,2]
- C1272696
- UMLS CUI [1,3]
- C3840932
- UMLS CUI [1,4]
- C1521902
Beschrijving
I HAVE READ THESE CASE REPORT FORMS AND CONFIRM THAT THE INFORMATION GIVEN IS ACCURATE AND COMPLETE
Alias
- UMLS CUI-1
- C2346576
Similar models
Study Completion
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,2])
C0449867 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,4])
C1527415 (UMLS CUI [1,2])
C0003281 (UMLS CUI [2,1])
C0443315 (UMLS CUI [2,2])
C0205197 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
C1272696 (UMLS CUI-2)
C0205269 (UMLS CUI [1,2])
C0574032 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0598333 (UMLS CUI [2,1])
C0231180 (UMLS CUI [2,2])
C1272696 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,3])
C1272696 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
Geen commentaren